Cite
Honkanen EA, Eklund M, Nuuttila S, et al. Dopamine transporter binding in symptomatic controls and healthy volunteers: Considerations for neuroimaging trials. Neuroimage Clin. 2021;32:102807doi: 10.1016/j.nicl.2021.102807.
Honkanen, E. A., Eklund, M., Nuuttila, S., Noponen, T., Jaakkola, E., Mäkinen, E., Hirvilammi, R., Seppänen, M., Lindholm, K., Scheperjans, F., Parkkola, R., Joutsa, J., Varrone, A., & Kaasinen, V. (2021). Dopamine transporter binding in symptomatic controls and healthy volunteers: Considerations for neuroimaging trials. NeuroImage. Clinical, 32102807. https://doi.org/10.1016/j.nicl.2021.102807
Honkanen, Emma A, et al. "Dopamine transporter binding in symptomatic controls and healthy volunteers: Considerations for neuroimaging trials." NeuroImage. Clinical vol. 32 (2021): 102807. doi: https://doi.org/10.1016/j.nicl.2021.102807
Honkanen EA, Eklund M, Nuuttila S, Noponen T, Jaakkola E, Mäkinen E, Hirvilammi R, Seppänen M, Lindholm K, Scheperjans F, Parkkola R, Joutsa J, Varrone A, Kaasinen V. Dopamine transporter binding in symptomatic controls and healthy volunteers: Considerations for neuroimaging trials. Neuroimage Clin. 2021 Aug 30;32:102807. doi: 10.1016/j.nicl.2021.102807. Epub 2021 Aug 30. PMID: 34482280; PMCID: PMC8416950.
Copy
Download .nbib